Notably, a recent study by Zussy et al. shows that the intranasal administration of nanovectorized DHA decreases the phosphorylation of Tau and restores cognitive functions in two complementary AD murine models, paving the way for the development of new approaches to prevent or treat AD [186]. This evidence concerns the gene MAPT and Alzheimer disease.